November 30, 2018
Dr. Reddy's Laboratories Inc. issued a voluntary recall for 4212 blister packs of clopidogrel tablets, USP, 300 mg (NDC 55111-671-31), because the drug failed to meet dissolution specifications during 18-month testing, according to the November 28, 2018, US Food and Drug Administration (FDA) Enforcement Report.
The 30-count blister packs recalled are from lot T600530, which has a November 2018 expiration date. The product was distributed throughout the United States.
Dr. Reddy's Laboratories issued the recall November 7, 2018. On November 27, 2018, the FDA designated the recall Class II, signaling use of the affected drugs may cause temporary or medically reversible adverse health consequences or a remote possibility of serious harm.
Clopidogrel is a prescription blood thinner used to prevent stroke, heart attack, and other heart problems.
For more Pharmacy Learning Network articles, visit the homepage
To learn about Pharmacy Learning Network Live meetings, click here